Individuals in both the Bahamas and Montana are currently permitted to access experimental medications years in advance of standard regulatory approval. Within the longevity space, this development has completely shifted the conversation. We are no longer wondering if these treatments will become accessible. Instead, the pressing questions are who gets to use them, how safely they can be administered, and what the financial cost will be.
We are very interested in hearing your perspective on these issues. In partnership with LARTA and Wildcreek Life Sciences, we are hosting an anonymous survey that will only require 10 to 15 minutes of your time. We invite you to share your valuable feedback by following the link below.
https://docs.google.com/forms/d/e/1FAIpQLSflnN6mbjxfYAvKLvlII8kHVtr59L5Mpc6KbzyMafD_zgaTPQ/viewform
We are very interested in hearing your perspective on these issues. In partnership with LARTA and Wildcreek Life Sciences, we are hosting an anonymous survey that will only require 10 to 15 minutes of your time. We invite you to share your valuable feedback by following the link below.
https://docs.google.com/forms/d/e/1FAIpQLSflnN6mbjxfYAvKLvlII8kHVtr59L5Mpc6KbzyMafD_zgaTPQ/viewform